COVID-19 Products Had Strong 2021, But Omicron Casts Shadow Over 2022

Windfall From Drugs, Vaccines Sparks Talk Of Merger Mania

 
• By Alaric DeArment
COVID globe
How the drug and vaccine market developed in 2021, and how Omicron hangs over 2022 • Source: Shutterstock

More from COVID-19

More from Scrip